Pharmacokinetics and tissue distribution of betulinic acid in CD-1 mice

Biopharmaceutics and Drug Disposition

Volumn 20, Issue 8, 1999, Pages 379-383

  Udeani, George O ^a   Zhao, Guo Min ^a   Shin, Young Geun ^a   Cooke, Blaire P ^a   Graham, James ^a   Beecher, Christopher W W ^a   Kinghorn, A Douglas ^a   Pezzuto, John M ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Betulinic acid; Pharmacokinetics; Tissue distribution

Indexed keywords

BETULIC ACID; FAT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER; BRAIN; CECUM; COLON; HEART; KIDNEY; LIVER; LUNG; LYMPH NODE; MAMMARY GLAND; MOUSE; NONHUMAN; OVARY; SKIN; SMALL INTESTINE; SPLEEN; THYMUS; TISSUE DISTRIBUTION; UTERUS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; FEMALE; MICE; TISSUE DISTRIBUTION; TRITERPENES;

EID: 0033364579     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-081X(199911)20:8<379::AID-BDD198>3.0.CO;2-C     Document Type: Article

References (15)

1. Sober AJ, Koh HK, Tran N-LT, Washington Jr CV. Melanoma and other skin cancers. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, and Longo DL (eds) Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 1998; 543-549.
2. Albino AP, Reed JA, McNutt NS. Malignant melanoma. In: Devita Jr VT, Hellman S, Rosenberg SA (eds) Cancer: Principles of Practice of Oncology. Philadelphia: Lippincott-Raven, 1997; 1935-1946.
3. Anonymous. Cancer Facts and Figures. Atlanta, GA: American Cancer Society, 1997.
4. Pisha E, Cahi H, Lee I-S, Chagwedera TE, Farnsworth NR, Cordell GA, Beecher CWW, Fong HHS, Kinghorn AD, Brown DM, Wani MC, Wall ME, Hieken TJ, Das Gupta TK, Pezzuto JM. Discovery of betulinic as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nature Med 1995; 1: 1046-1051.
5. Kinghorn AD, Farnsworth NR, Beecher CWW, Soejarto DD, Cordell GA, Pezzuto JM, Wall ME, Wani MC, Brown DM, O'Neill MJ, Lewis JA, Besterman JM. Novel strategies for plant-derived anti-cancer agents. In: A-ur Ruhman A, Choudhary MI (eds) New Trends in Natural Product Chemistry. Amsterdam: Harwood Academic Publishers, 1998; 79-94.
6. Fulda S, Friesen C, Los M, Scaffidi C, Mier W, Benedict M, Nunez G, Krammer PH, Peter ME, Debatin K-M. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res 1997; 57: 4956-4964.
7. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998; 281: 1305-1308.
8. O'Connell MM, Bently MD, Campbell CS, Cole BJW. Betulin and lupeol in bark from four white-barked birches. Phytochemistry 1998; 27: 2175-2176.
9. Kim DSHL, Chen Z, Nguyen T, Pezzuto JM, Qiu S, Lu Z-Z. A concise semi-synthetic approach to betulinic acid from betulin. Synthet Commun 1997; 27: 1607-1612.
10. Kim DSHL, Pezzuto JM, Pisha E. Synthesis of betulinic acid derivatives with activity against human melanoma. Bioorg Med Chem Lett 1998; 8: 1707-1712.
11. Evers M, Poujade C, Soler F, Ribeill Y, James C, Leliévre Y, Gueguen J-C, Reisdorf D, Morize I, Pauwels R, De Clecq E, Henin Y, Bousseau A, Mayaux J-F, Le Pecq J-B, Dereu N. Betulinic acid derivatives: A new class of human immunodeficiency virus type I specific inhibitors with a new mode of action. J Med Chem 1996; 39: 1056-1068.
12. Yoshiki K, Hashimoto F, Cosentino LM, Chen C-H, Garrett PE, Lee K-H. Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents. J Med Chem 1996; 39: 1016-1017.
13. Waller DP, Zaneveld LJ, Fong HH. In vitro spermicidal activity of gossylpol. Contraception 1980; 22: 183-187.
14. Anonymous. WinNonlin Software Package. Apex, NC: Scientific Consulting Inc., 1995.
15. Son BL, Kaplun AP, Symon AV, Shpilevsky AA, Grigoriev VB, Shvets VI. Solubilization of betulinic acid, a new anti-melanoma compound. Proceed Int Symp Control Rel Bioact Mater 1998; 25: 419-420.